These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1489898)
1. Evidence for activation of coagulation in Crohn's disease. Hudson M; Hutton RA; Wakefield AJ; Sawyerr AM; Pounder RE Blood Coagul Fibrinolysis; 1992 Dec; 3(6):773-8. PubMed ID: 1489898 [TBL] [Abstract][Full Text] [Related]
2. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637 [TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. Weber P; Husemann S; Vielhaber H; Zimmer KP; Nowak-Göttl U J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):418-22. PubMed ID: 10204507 [TBL] [Abstract][Full Text] [Related]
4. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Smith CJ; Haire WD; Kaufman SS; Mack DR Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175 [TBL] [Abstract][Full Text] [Related]
5. Fibrin formation and degradation in patients with arteriosclerotic disease. Herren T; Stricker H; Haeberli A; Do DD; Straub PW Circulation; 1994 Dec; 90(6):2679-86. PubMed ID: 7994808 [TBL] [Abstract][Full Text] [Related]
6. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Merlini PA; Bauer KA; Oltrona L; Ardissino D; Cattaneo M; Belli C; Mannucci PM; Rosenberg RD Circulation; 1994 Jul; 90(1):61-8. PubMed ID: 8026047 [TBL] [Abstract][Full Text] [Related]
7. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy. Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109 [TBL] [Abstract][Full Text] [Related]
8. Activation of coagulation and fibrinolysis in open and laparoscopic cholecystectomy. Dexter SP; Griffith JP; Grant PJ; McMahon MJ Surg Endosc; 1996 Nov; 10(11):1069-74. PubMed ID: 8881054 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154 [TBL] [Abstract][Full Text] [Related]
10. No evidence of activated blood coagulation in Crohn's disease. Novacek G; Kapiotis S; Moser G; Speiser W; Gangl A; Vogelsang H Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):963-7. PubMed ID: 9391785 [TBL] [Abstract][Full Text] [Related]
11. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation. Solymoss S; Bovill EG Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609 [TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis. Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW Pathophysiol Haemost Thromb; 2003; 33(2):75-83. PubMed ID: 14624048 [TBL] [Abstract][Full Text] [Related]
13. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Edwards RL; Levine JB; Green R; Duffy M; Mathews E; Brande W; Rickles FR Gastroenterology; 1987 Feb; 92(2):329-37. PubMed ID: 3792769 [TBL] [Abstract][Full Text] [Related]
14. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA. Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409 [TBL] [Abstract][Full Text] [Related]
15. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817 [TBL] [Abstract][Full Text] [Related]
16. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency. Herren T; Straub PW; Haeberli A Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646 [TBL] [Abstract][Full Text] [Related]
17. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409 [TBL] [Abstract][Full Text] [Related]
18. [Biological manifestations of a prethrombotic state in developmental Crohn's disease]. Chamouard P; Grunebaum L; Duclos B; Wiesel L; Cazenave JP Gastroenterol Clin Biol; 1990; 14(3):203-8. PubMed ID: 2188861 [TBL] [Abstract][Full Text] [Related]
19. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis]. Uchida Y Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013 [TBL] [Abstract][Full Text] [Related]
20. Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate. Hampton KK; Preston FE; Lowe GD; Walker ID; Sampson B Br J Haematol; 1993 Jun; 84(2):279-84. PubMed ID: 8398831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]